why choose us

First received: October 18, 2022

Clinical Trial: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Leukemia

Study Type: INTERVENTIONAL


Official Title: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Brief Summary: The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marrow from a deceased donor in patients with acute leukemias.Patients will either receive myeloablative conditioning or reduced intensity conditioning regimen prior to the transplant.Patients will be followed for 56 days for safety endpoints and remain in follow-up for one year.

Read more